(Q33622195)

English

Equivalent weight loss with marked metabolic benefit observed in a matched cohort with and without type 2 diabetes 12 months following gastric bypass surgery

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Equivalent weight loss with marked metabolic benefit observed in a matched cohort with and without type 2 diabetes 12 months following gastric bypass surgery (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

type 2 diabetes

1 reference

based on heuristic

inferred from title

author name string

Kathleen Yip

1

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Leslie Heinberg

2

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Victoria Giegerich

3

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Philip R Schauer

4

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Sangeeta R Kashyap

5

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

publication date

1 November 2012

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Obesity Surgery

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

22

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

1723-1729

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Factors related to weight loss up to 4 years after bariatric surgery

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4023564

28 July 2018

Re-emergence of diabetes after gastric bypass in patients with mid- to long-term follow-up

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4023564

28 July 2018

Analysis of factors associated with durable remission of diabetes after Roux-en-Y gastric bypass

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4023564

28 July 2018

Metabolic syndrome and risk of cardiovascular disease: a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4023564

28 July 2018

Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4023564

28 July 2018

Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4023564

28 July 2018

Glycemic control continues to deteriorate after sulfonylureas are added to metformin among patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0719-8

21 January 2018

Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0719-8

21 January 2018

Glycemic control from 1988 to 2000 among U.S. adults diagnosed with type 2 diabetes: a preliminary report

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0719-8

21 January 2018

Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0719-8

21 January 2018

Bariatric surgery: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0719-8

21 January 2018

Preoperative factors predicting remission of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery for obesity

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0719-8

21 January 2018

Does diabetes affect weight loss after gastric bypass?

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0719-8

21 January 2018

Suboptimal weight loss after gastric bypass surgery: correlation of demographics, comorbidities, and insurance status with outcomes

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0719-8

21 January 2018

Weight loss and health outcomes in African Americans and whites after gastric bypass surgery

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0719-8

21 January 2018

Predictive factors of excess body weight loss 1 year after laparoscopic bariatric surgery

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0719-8

21 January 2018

Long-term outcomes after gastric bypass

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0719-8

21 January 2018

U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group

2 references

https://api.crossref.org/works/10.1007%2FS11695-012-0719-8

21 January 2018

https://pubmed.ncbi.nlm.nih.gov/22895804

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of Laparoscopic Roux-En Y Gastric Bypass on Type 2 Diabetes Mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4023564

30 October 2018

The Role of β-Cell Function and Insulin Sensitivity in the Remission of Type 2 Diabetes after Gastric Bypass Surgery

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0719-8

21 January 2018

Early and longer term effects of gastric bypass surgery on tissue-specific insulin sensitivity and beta cell function in morbidly obese patients with and without type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0719-8

21 January 2018

Identifiers

10.1007/S11695-012-0719-8

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33622195&oldid=2195579966"